Hyperphosphatemia occurs when the homeostasis of phosphate is altered, as described in patients with CKD and in the premature aging syndromes presented in the Klotho mice and FGF23 KO mice (Razzaque et al., 2006; Nakatani et al., 2009). The gene discussed is FGF23; the disease is chronic kidney disease.